Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy

PURPOSE: Antiangiogenic therapy is commonly being used for the treatment of glioblastoma. However, the benefits of angiogenesis inhibitors are typically transient and resistance often develops. Determining the mechanism of treatment failure of the VEGF monoclonal antibody bevacizumab for malignant g...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Oncotarget
मुख्य लेखकों: Liang, Ji, Piao, Yuji, Henry, Verlene, Tiao, Ningyi, de Groot, John F.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Impact Journals LLC 2015
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741619/
https://ncbi.nlm.nih.gov/pubmed/26362401
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन